Messenger RNA expression profiling using DNA microarray technology: Diagnostic tool, scientific analysis or un-interpretable data? (Review)

International Journal of Molecular Medicine

Volumn 21, Issue 1, 2008, Pages 13-17

  Walker, Moira S ^a   Hughes, Thomas A ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Microarray technology; Transcriptome

Indexed keywords

GENOMIC DNA; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTOME;

ALTERNATIVE RNA SPLICING; B CELL LYMPHOMA; BIOTECHNOLOGY; CELL LABELING; CONCENTRATION (PARAMETERS); DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DNA DAMAGE; DNA DETERMINATION; DNA MICROARRAY; DNA PROBE; DNA REPAIR; DNA SEQUENCE; FLUORESCENCE ANALYSIS; GENE ACTIVITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENETIC ALGORITHM; GENETIC DATABASE; GENETIC DISORDER; GENETIC VARIABILITY; GENOME ANALYSIS; GENOMICS; HODGKIN DISEASE; HUMAN; INTOXICATION; LASER MICRODISSECTION; MEDICAL RESEARCH; MICROARRAY ANALYSIS; MUTATIONAL ANALYSIS; NORTHERN BLOTTING; ONCOGENE; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEOMICS; QUALITY CONTROL; QUANTITATIVE DIAGNOSIS; REFERENCE DATABASE; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA ANALYSIS; STANDARDIZATION; TOXICOGENETICS; TOXICOKINETICS; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

EID: 38949172372     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.21.1.13     Document Type: Review

References (69)

1. Lockhart DJ and Winzeler EA: Genomics, gene expression and DNA arrays. Nature 405: 827-836, 2000.
2. Schena M, Shalon D, Davis RW and Brown PO: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270: 467-470, 1995.
3. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503-517, 1975.
4. Lander ES: Array of hope. Nat Genet 21 (suppl 1): 3-4, 1999.
5. Lockhart DJ, Dong H, Byrne MC, et al: Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotech 14: 1675-1680, 1996.
6. Lipshutz RJ, Fodor SP, Gingeras TR and Lockhart DJ: High density synthetic oligonucleotide arrays. Nat Genet 21 (Suppl 1): 20-24,1999.
7. Fodor SP, Read JL, Pirrung MC, Stryer L, Lu AT and Salas D: Light-directed, spatially addressable parallel chemical synthesis. Science 251: 767-773, 1991.
8. Johnson JM, Edwards S, Shoemaker D and Schadt EE: Dark matter in the genome: evidence of widespread transcription detected by microarray tiling experiments. Trends Genet 21: 93-102, 2005.
9. Lobenhofer EK, Bushel PR, Afshari CA and Hamadeh HK: Progress in the application of DNA microarrays. Environ Health Perspect 109: 881-891, 2001.
10. Golub TR, Slonim DK, Tamayo P, et al: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537, 1999.
11. Shoemaker DD and Linsley PS: Recent developments in DNA microarrays. Curr Opin Microbiol 5: 334-337, 2002.
12. Rosenwald A, Wright G, Leroy K, et al: Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favourable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 198: 851-862, 2003.
13. Savage KJ, Monti S, Kutok JL, et al: The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 102: 3871-3879, 2003.
14. Welsh JB, Zarrinkar PP, Sapinoso LM, et al: Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci USA 98: 1176-1181, 2001.
15. Dhanasekaran SM, Barrette TR, Ghosh D, et al: Delineation of prognostic biomarkers in prostate cancer. Nature 412: 822-826, 2001.
16. Martin KJ, Kritzman BM, Price LM, et al: Linking gene expression patterns to therapeutic groups in breast cancer. Cancer Res 60: 2232-2238, 2000.
17. Van't Veer LJ, Dai H, van de Vijver MJ, et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536, 2002.
18. Hutchinson E: Tumour classification: recognising differences. Nat Rev Cancer 3: 716-717, 2003.
19. Feng X, Jiang Y, Meltzer P and Yen PM: Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol Endocrinol 14: 947-955, 2000.
20. Yen PM: Studying hormonal regulation by microarrays: distinguishing the trees from the forest. J Clin Endocrinol Metab 90: 1241-1242, 2005.
21. Kannan K, Kaminski N, Rechavi G, Jakob-Hirsch J, Amariglio N and Givol D: DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1. Oncogene 20: 3449-3455, 2001.
22. Sax JK and El-Deiry WS: p53-induced gene expression analysis. Methods Mol Biol 234: 65-71, 2003.
23. Hamadeh HK, Bushel PR, Jayadev S, et al: Gene expression analysis reveals chemical-specific profiles. Toxicol Sci 67: 219-231, 2002.
24. Burczynski ME, McMillian M, Ciervo J, et al: Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. Toxicol Sci 58: 399-415, 2000.
25. Lettieri T: Recent applications of DNA microarray technology to toxicology and ecotoxicology. Environ Health Perspect 114: 4-9, 2006.
26. Waring JF, Ciurlionis R, Jolly RA, Heindel M and Ulrich RG: Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol Lett 120: 359-368, 2001.
27. Tennant RW: The National Center for Toxicogenomics: using new technologies to inform mechanistic toxicology. Environ Health Perspect 110: A8-A10, 2002.
28. Andrew AS, Warren AJ, Barchowsky A, et al: Genomic and proteomic profiling of responses to toxic metals in human lung cells. Environ Health Perspect 111: 825-835, 2003.
29. Slonim DK: From patterns to pathways: gene expression data analysis comes of age. Nat Genet 32 (Suppl): 502-508, 2002.
30. Shields R: MIAME, we have a problem. Trends Genet 22: 65-66, 2006.
31. Kuo WP, Jenssen TK, Butte AJ, Ohno-Machado L and Kohane IS: Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics 18: 405-412, 2002.
32. Grunenfelder B and Winzeler EA: Treasures and traps in genome-wide data sets: case examples from yeast. Nat Rev Genet 3: 653-661, 2002.
33. Irizarry RA, Warren D, Spencer F, et al: Multiple-laboratory comparison of microarray platforms. Nat Methods 2: 345-350, 2005.
34. Bammler T, Beyer RP, Bhattacharya S, et al: Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods 2: 351-356, 2005.
35. Draghici S, Khatri P, Eklund AC and Szallasi Z: Reliability and reproducibility issues in DNA microarray measurements. Trends Genet 22: 101-109, 2006.
36. Chuaqui RF, Bonner RF, Best CJ, et al: Post-analysis follow-up and validation of microarray experiments. Nat Genet 32 (Suppl): 509-514, 2002.
37. Butte A: The use and analysis of microarray data. Nat Rev Drug Discovery 1: 951-960, 2002.
38. Simone NL, Bonner RF, Gillespie JW, Emmert-Buck MR and Liotta LA: Laser-capture microdissection: opening the microscopic frontier to molecular analysis. Trends Genet 14: 272-276, 1998.
39. O'Dell DM, McIntosh TK and Eberwine JH: Single-cell molecular biology: implications for the diagnosis and treatment of neurological disease. Arch Neurol 56: 1453-1456, 1999.
40. Cole KA, Krizman DB and Emmert-Buck MR: The genetics of cancer - a 3D model. Nat Genet 21 (Suppl 1): 38-41, 1999.
41. Anonymous: Under the MIAME sun. Nat Methods 3: 415, 2006.
42. Brazma A, Hingamp P, Quackenbush J, et al: Minimum information about a microarray experiment (MIAME) - toward standards for microarray data. Nat Genet 29: 365-371, 2001.
43. Stoeckert CJ Jr, Causton HC and Ball CA: Microarray databases: standards and ontologies. Nat Genet 32 (Suppl): 469-473, 2002.
44. Miron M and Nadon R: Inferential literacy for experimental high-throughput biology. Trends Genet 22: 84-89, 2006.
45. Day DA and Tuite MF: Post-transcriptional gene regulatory mechanisms in eukaryotes: an overview. J Endocrinol 157: 361-371, 1998.
46. International Human Genome Sequencing Consortium: Initial sequencing and analysis of the human genome. Nature 409: 860-921, 2001.
47. Modrek B and Lee C: A genomic view of alternative splicing. Nat Genet 30: 13-19, 2002.
48. Mironov AA, Fickett IW and Gelfand MS: Frequent alternative splicing of human genes. Genome Res 9: 1288-1293, 1999.
49. Kan Z, Rouchka EC, Gish WR and States DJ: Gene structure prediction and alternative splicing analysis using genomically aligned ESTs. Genome Res 11: 889-900, 2001.
50. Modrek B, Resch A, Grasso C and Lee C: Genome-wide analysis of alternative splicing using human expressed sequence data. Nucleic Acids Res 29: 2850-2859, 2001.
51. Krawczak M, Reiss I and Cooper DN: The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90: 41-54, 1992.
52. Liu HX, Cartegni L, Zhang MQ and Krainer AR: A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet 27: 55-58, 2001.
53. Clark TA, Schweitzer AC, Chen TX, Staples MK, Lu G, Wang H, Williams A and Blume JE: Discovery of tissue-specific exons using comprehensive human exon microarrays. Genome Biol 8: R64, 2007.
54. Hughes TA: 5′ untranslated regions: critical regulators of cap-dependent translation. In: Leading-Edge Messenger RNA Research Communications. Ostrovskiy MH (ed). Nova Science Publishers, New York, pp 16-29, 2007.
55. Garcia-Sanz LA, Mikulits W, Livingstone A, Lefkovits I and Mullner EW: Translational control: a general mechanism for gene regulation during T cell activation. FASEB J 12: 299-306, 1998.
56. Anderson L and Seilhamer J: A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18: 533-537, 1997.
57. Gygi SP, Rochon Y, Franza BR and Aebersold R: Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19: 1720-1730, 1999.
58. Valencia-Sanchez MA, Liu J, Hannon GJ and Parker R: Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Devel 20: 515-524, 2006.
59. Storz G, Altuvia S and Wassarman KM: An abundance of RNA regulators. Ann Rev Biochem 74: 199-217, 2005.
60. Gottesman S: The small RNA regulators of Escherichia coli: roles and mechanisms. Ann Rev Microbiol 58: 303-328, 2004.
61. Nakamoto M, Jin P, O'Donnell WT and Warren ST: Physiological identification of human transcripts translationally regulated by a specific microRNA. Hum Mol Genet 14: 3813-3821, 2005.
62. Hu Z, Zhang A, Storz G, Gottesman S and Leppla SH: An antibody-based microarray assay for small RNA detection. Nucleic Acid Res 34: E52, 2006.
63. Zong Q, Schummer M, Hood L and Morris DR: Messenger RNA translation state: the second dimension of high-throughput expression screening. Proc Natl Acad Sci USA 96: 10632-10636, 1999.
64. Pradet-Balade B, Boulme F, Beug H, Mullner EW and Garcia-Sanz JA: Translation control: bridging the gap between genomics and proteomics? Trends Biochem Sci 26: 225-229, 2001.
65. Anderson NL and Anderson NG: Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis 19: 1853-1861,1998.
66. Winssinger N, Ficarro S, Schultz PG and Harris JL: Profiling protein function with small molecule microarrays. Proc Natl Acad Sci USA 99: 11139-11144, 2002.
67. Kirschner M: Intracellular proteolysis. Trends Cell Biol 9: M42-M45,1999.
68. Dove A: Proteomics: translating genomics into products? Nat Biotech 17: 233-236, 1999.
69. Celis JE, Kruhoffer M, Gromova I, et al: Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics. FEBS Lett 480: 2-16, 2000.